Novel Pharmacotherapies for Type 2 Diabetes
2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 131-138
Over the past five years, the therapeutic landscape of type 2 diabetes mellitus (T2DM) has expanded with the emergence of novel pharmacotherapies targeting diverse pathophysiological pathways. These agents, including incretin-based therapies, dual and triple...